Funds holding SILO PHARMA INC
ISIN US82711P2011 · United States
- Fund holders
- 5
- Of which ETFs
- 1 4 other funds
- Value held
- 275.2K $
- Share of capital
- 48.1 % of 1.6M shares on Aug 13, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 663,965 | 238.8K $ | 1.18 % | 41.80 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 75,837 | 27.8K $ | 0.00 % | 4.77 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 11,221 | 4K $ | 0.71 % | as of Mar 31, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 8,423 | 3.1K $ | 0.53 % | as of Feb 28, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 3,896 | 1.4K $ | 0.25 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 1.18 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 5 | 0 | 763,342 | +17.7 % |
| 2026Q1 | 5 | 0 | 648,343 | +56.6 % |
| 2025Q4 | 5 | 0 | 413,894 | +73.0 % |
| 2025Q3 | 5 | 0 | 239,209 | +36.7 % |
| 2025Q2 | 5 | +1 | 175,007 | +240.0 % |
| 2025Q1 | 4 | +1 | 51,476 | +60.5 % |
| 2024Q4 | 3 | 0 | 32,067 | -0.7 % |
| 2024Q3 | 3 | 0 | 32,304 | -0.4 % |
| 2024Q2 | 3 | 0 | 32,440 | -0.2 % |
| 2024Q1 | 3 | 0 | 32,513 | -15.9 % |
| 2023Q4 | 3 | 38,666 |
Institutional managers
12 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| AdvisorShares Investments LLC | 663,965 | 238.8K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 180,031 | 64.8K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 62,795 | 22.6K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 44,763 | 16.1K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 21,448 | 7.7K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 17,083 | 6.1K $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 14,503 | 5.2K $ | as of Mar 31, 2026 |
| LPL Financial LLC | 12,534 | 4.5K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 12,500 | 4.5K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,677 | 603 $ | as of Mar 31, 2026 |
| IFP Advisors, Inc | 175 | 63 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 10 | 4 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding SILO PHARMA INC". https://titelia.com/en/stocks/silo-pharma-inc-US82711P2011